XML 40 R26.htm IDEA: XBRL DOCUMENT
v3.23.1

Note 2 - Revenue (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2023
Notes Tables |
Disaggregation of Revenue [Table Text Block] |
|  | Year Ended March 31, 2023 |
|  | Clinical Genomics (1) |  |  | Sterilization and Disinfection Control |  |  | Biopharmaceutical Development |  |  | Calibration Solutions |  |  | Total |
Consumables |  | $ | 43,374 |  |  | $ | 55,605 |  |  | $ | 15,800 |  |  | $ | 3,062 |  |  | $ | 117,841 |
Hardware and Software |  |  | 13,347 |  |  |  | 692 |  |  |  | 22,079 |  |  |  | 26,561 |  |  |  | 62,679 |
Services |  |  | 5,578 |  |  |  | 8,312 |  |  |  | 9,486 |  |  |  | 15,184 |  |  |  | 38,560 |
Total Revenues |  | $ | 62,299 |  |  | $ | 64,609 |  |  | $ | 47,365 |  |  | $ | 44,807 |  |  | $ | 219,080 |
|  | Year Ended March 31, 2022 |
|  | Clinical Genomics (1) |  |  | Sterilization and Disinfection Control |  |  | Biopharmaceutical Development |  |  | Calibration Solutions |  |  | Total |
Consumables |  | $ | 22,271 |  |  | $ | 50,311 |  |  | $ | 15,551 |  |  | $ | 3,675 |  |  | $ | 91,808 |
Hardware and Software |  |  | 6,726 |  |  |  | 700 |  |  |  | 21,651 |  |  |  | 28,537 |  |  |  | 57,614 |
Services |  |  | 3,843 |  |  |  | 8,033 |  |  |  | 8,377 |  |  |  | 14,660 |  |  |  | 34,913 |
Total Revenues |  | $ | 32,840 |  |  | $ | 59,044 |  |  | $ | 45,579 |  |  | $ | 46,872 |  |  | $ | 184,335 |
|  | Year Ended March 31, 2021 |
|  | Clinical Genomics (1) |  |  | Sterilization and Disinfection Control |  |  | Biopharmaceutical Development |  |  | Calibration Solutions |  |  | Total |
Consumables |  | $ | - |  |  | $ | 45,869 |  |  | $ | 13,942 |  |  | $ | 3,198 |  |  | $ | 63,009 |
Hardware and Software |  |  | - |  |  |  | 505 |  |  |  | 13,545 |  |  |  | 29,969 |  |  |  | 44,019 |
Services |  |  | - |  |  |  | 6,745 |  |  |  | 6,405 |  |  |  | 13,759 |  |  |  | 26,909 |
Total Revenues |  | $ | - |  |  | $ | 53,119 |  |  | $ | 33,892 |  |  | $ | 46,926 |  |  | $ | 133,937 |
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] |
Contract liabilities as of March 31, 2022 |  | $ | 15,069 |
Prior year liabilities recognized in revenues during the year ended March 31, 2023 |  |  | (8,643 | )
Contract liabilities added during the year ended March 31, 2023, net of revenues recognized |  |  | 9,672 |
Contract liabilities balance as of March 31, 2023 |  | $ | 16,098 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration